Insufficient scRNA-seq data for expression of PAOX at single-cell level.
Insufficient scRNA-seq data for expression of PAOX at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 533.89 | 245 / 245 | 83% | 2.39 | 419 / 502 |
ovary | 100% | 347.87 | 180 / 180 | 69% | 1.08 | 295 / 430 |
liver | 100% | 705.67 | 226 / 226 | 45% | 0.78 | 183 / 406 |
esophagus | 100% | 512.76 | 1442 / 1445 | 40% | 0.55 | 73 / 183 |
stomach | 100% | 299.55 | 358 / 359 | 28% | 0.43 | 81 / 286 |
uterus | 100% | 368.80 | 170 / 170 | 25% | 0.40 | 117 / 459 |
intestine | 100% | 428.86 | 966 / 966 | 23% | 0.34 | 119 / 527 |
bladder | 100% | 388.62 | 21 / 21 | 22% | 0.34 | 110 / 504 |
kidney | 100% | 453.20 | 89 / 89 | 21% | 0.32 | 190 / 901 |
thymus | 100% | 285.23 | 651 / 653 | 21% | 0.34 | 127 / 605 |
breast | 100% | 340.24 | 459 / 459 | 12% | 0.16 | 135 / 1118 |
lung | 98% | 256.58 | 568 / 578 | 11% | 0.16 | 131 / 1155 |
pancreas | 99% | 221.80 | 324 / 328 | 10% | 0.13 | 18 / 178 |
brain | 100% | 323.64 | 2633 / 2642 | 4% | 0.06 | 29 / 705 |
adrenal gland | 100% | 321.62 | 257 / 258 | 2% | 0.02 | 4 / 230 |
spleen | 100% | 785.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.36 | 1 / 1 |
skin | 99% | 326.99 | 1791 / 1809 | 1% | 0.01 | 3 / 472 |
blood vessel | 100% | 294.39 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 282.75 | 1199 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 219.31 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 92% | 136.50 | 796 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 1.71 | 25 / 29 |
peripheral blood | 83% | 276.50 | 769 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 0.58 | 16 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046208 | Biological process | spermine catabolic process |
GO_1901307 | Biological process | positive regulation of spermidine biosynthetic process |
GO_0046203 | Biological process | spermidine catabolic process |
GO_0009447 | Biological process | putrescine catabolic process |
GO_0009446 | Biological process | putrescine biosynthetic process |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0052903 | Molecular function | N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity |
GO_0052899 | Molecular function | N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity |
GO_0046592 | Molecular function | polyamine oxidase activity |
GO_0052904 | Molecular function | N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity |
GO_0052902 | Molecular function | spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity |
GO_0052901 | Molecular function | spermine:oxygen oxidoreductase (spermidine-forming) activity |
Gene name | PAOX |
Protein name | Polyamine oxidase (Exo-N4-amino), isoform CRA_d (cDNA FLJ46119 fis, clone TESTI2037877, highly similar to Peroxisomal N1-acetyl-spermine/spermidineoxidase) Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase) |
Synonyms | hCG_19149 UNQ1923/PRO4398 PAO |
Description | FUNCTION: Flavoenzyme which catalyzes the oxidation of N(1)-acetylspermine to spermidine and is thus involved in the polyamine back-conversion . Can also oxidize N(1)-acetylspermidine to putrescine. Substrate specificity: N(1)-acetylspermine = N(1)-acetylspermidine > N(1),N(12)-diacylspermine >> spermine. Does not oxidize spermidine. Plays an important role in the regulation of polyamine intracellular concentration and has the potential to act as a determinant of cellular sensitivity to the antitumor polyamine analogs . . |
Accessions | Q6QHF9 ENST00000357296.7 [Q6QHF9-4] ENST00000468317.3 ENST00000529585.5 [Q6QHF9-6] ENST00000356306.9 [Q6QHF9-5] ENST00000476834.6 [Q6QHF9-6] ENST00000278060.10 [Q6QHF9-2] ENST00000483211.6 [Q6QHF9-6] ENST00000480071.2 [Q6QHF9-5] B0QZA9 |